key: cord-0948291-7bg0r0xe authors: Novak, Helena; Tadić, Ivana; Falamić, Slaven; Hadžiabdić, Maja Ortner title: Pharmacists’ Role, Work Practices, and Safety Measures against COVID-19: A Comparative Study date: 2021-03-17 journal: J Am Pharm Assoc (2003) DOI: 10.1016/j.japh.2021.03.006 sha: e44bfed1640343e3f0672dbd9395f65af191bbb8 doc_id: 948291 cord_uid: 7bg0r0xe Background The coronavirus disease (COVID-19) pandemic poses a great challenge to health systems and their most accessible assets—community pharmacies. Pharmacists faced many challenges such as incorporating safety measures, changes in working schedule and workload, and meeting specific patients’ needs. Objectives This study aimed to explore and compare the community pharmacists’ roles, practices, implemented safety measures, and psychological toll in Croatia and Serbia during the COVID-19 pandemic. Methods A cross-sectional study employing an online survey was conducted in two countries over a period of 6 weeks during 2020. The survey consisted of 65 items that explored sociodemographic characteristics of participants and their workplaces, including safety measures, pharmaceutical care, and their psychology while working during the COVID-19 pandemic. Results In total, 574 pharmacists participated in the study, of which 90% were female with a mean age of 38 years (interquartile range 30.5–47). Study identified new pharmacists’ roles that evolved during the COVID-19 pandemic; manufacturing hand sanitizers in community pharmacies, online patient counseling and medicine home delivery. Croatian and Serbian pharmacists exhibited disparities in their incorporated safety measures (higher for Croatia; p ≤ 0.001), satisfaction with work organization and counseling activities (higher for Serbia; p < 0.001). Serbian participants were less satisfied with the public perception of their role during the pandemic, and overall satisfaction was low, with a negative impact on mood and productivity. Conclusions The study revealed the implications for community pharmacists during the pandemic in both countries. The extent of systematic and logistical support provided to them during the pandemic could be an explanation for the highlighted differences. It is imperative to develop a more effective strategy to counter potential health crises to ensure a better response from primary care pharmacists in the future. What was already known 30 • Community pharmacies had to respond quickly to the coronavirus disease (COVID-19) 31 outbreak as frontline healthcare workers. 32 33 What this study adds 34 • The role of pharmacists evolved during the COVID-19 pandemic, and also included 35 manufacturing hand sanitizers in community pharmacies, online patient counseling, and 36 home delivery of medicines apart from their established roles. 37 • Increased workload and threat of infection due to exposure at workplace have an effect on 38 the psychological states of community pharmacists, regardless of the country where they 39 practice. 40 • The extent of systematic and logistical support for the pharmacists during the pandemic 41 could be responsible for the difference between the responses and satisfaction of the 42 pharmacists in the two countries. Community pharmacies had to respond quickly to the coronavirus disease (COVID- 19) 45 outbreak as frontline healthcare workers scrambled to support patients even after the introduction 46 of lockdown measures 1 . Besides the established duties, they had to also supply personal protective 47 equipment (PPE) like masks, disinfectants, hand sanitizers, face shields, gloves, and dietary 48 supplements. At the beginning of the pandemic, mass panic led to significantly higher demand for 49 PPEs causing shortages of these products. Moreover, they had to educate patients about 50 precautionary measures to prevent the spread of the virus, detect suspected cases early, and 51 provide referrals to appropriate hospitals 2 . 52 Therefore, new responsibilities evolved for pharmacists during the COVID-19 pandemic, as 53 they are the most accessible health care professionals at the primary healthcare level. They had to 54 make changes in care of patients with chronic diseases, along with the new roles. Therefore it is of 55 great importance to examine the work organization, implementation of precautionary measures, 56 provision of pharmaceutical care, and psychological aspects of pharmacy staff during the COVID- 19 57 pandemic, as all these affect the quality of services provided by the pharmacists. 58 Several reports have discussed the roles, preparedness, response [3] [4] [5] [6] [7] [8] , and stress 9,10 of 59 pharmacists during the COVID-19 pandemic. However, no study has covered all the aspects of 60 interest or involved a comprehensive analysis such as the one in this article. In particular, the data 61 on primary care pharmacists in European and American countries are lacking, when compared to the 62 data from Asian and African countries. 63 This is the first study to explore and compare the role of community pharmacists in two 64 European countries; the Republic of Croatia and the Republic of Serbia. Croatia and Serbia are 65 bordering countries and were once part of the same Republic, explaining the similarities in 66 languages, culture and educational system. Currently, Croatia, the high-income country, is a 67 European Union (EU) member state and Serbia, an upper-middle income country, is a candidate for 68 accession to the EU. Healthcare systems of both countries operate the Bismarck model. In Serbia, 69 unlike Croatia, there is no legally regulated demographic-geographic criterion for setting up a 70 pharmacy, and community pharmacies are predominately private, which influences the different 71 pharmacy service provisions in the two countries. Moreover, the two countries responded 72 differently to the pandemic and adopted different measures for their community pharmacists, as 73 presented in Table 1 Section C consisted of 22 questions on the provision of services during the pandemic, chronic 104 disease management, medication supply, patient consultation, and additional services offered, and 105 two questions on satisfaction with the prevailing public perception. The last section, Section D, 106 consisted of seven questions on the psychological effects of the pandemic (i.e., how the pharmacists 107 felt, the presence of fatigue and anxiety, etc.). 108 The designed questionnaire was then tested in a pilot studies, in Croatia and subsequently in 109 Serbia, over a 1-week period. First, 20 participants in Croatia were questioned on the clarity of each 110 question, to judge if all the questions were necessary, and to identify any potentially omitted 111 themes. Based on their responses, the survey was adjusted into a final version. The adaptation 112 involved the omission of three questions owing to similarity in meaning along with several small 113 changes, including offering additional answers in two questions related to work organization. A 114 panel of expert judges (2 faculty members) checked the readability and face validity of the items. 115 The final Croatian questionnaire was adapted for data collection in Serbia and was piloted 116 with eight participants in the country. It incorporated only small changes in line with local practice 117 investigating the type of pharmacy, its location, its work in accordance with the guidelines of official 118 bodies, the types of work shifts, and practice during and after total lockdown. After these changes 119 and pilot testing, principal investigators were consulted to achieve consensus on all changes. 120 J o u r n a l P r e -p r o o f Google Forms, a survey administration application, was used to configure the survey and collect 122 data. The data were collected over a 10-week period starting in June 2020 and July 2020, in Croatia 123 and Serbia, respectively. 124 Potential participants were invited through interest groups on social media, for example, the 125 Croatian Pharmaceutical Society Facebook page. Additionally, e-mail invitations were sent to the 126 largest community pharmacy chains in Serbia and community pharmacies in Croatia using the 127 available pharmacy database. Potential participants in Serbia were also invited through the 128 Pharmaceutical Chamber of Serbia. 129 Prior to participation in the survey, the short description of the study including the 130 information that the participation in a study would remain anonymous, voluntary, and the inputs of 131 participants would remain confidential, was specified and each pharmacist was asked if they agree 132 to voluntary participate or wanted more information about the study. In case of selection of the 133 second option more detailed information about the specific study aims were provided, followed by a 134 question to agree on voluntary participation. Only pharmacists who agreed to participate, based on 135 information provided, could continue to the survey questions. 136 In Croatia, the Ethical Committee of the Faculty of Pharmacy and Biochemistry, at the University of 138 Zagreb, exempted this research from the need to obtain ethical approval, clarifying that there were 139 no ethical dilemmas in any segment of the research while scientific contribution of the work was 140 reasonable and assumed. In Serbia, the Ethical Committee of the Pharmaceutical Chamber of Serbia 141 (No. 396-2, issued on July 8, 2020) issued ethical approval. 142 The results were reported using descriptive statistics, that is to say, the sample characteristics were 144 described and the results summarized on all explored aspects using mean (standard deviation), 145 median (interquartile range [IQR]), or percentages, as appropriate. To analyze differences between 146 the Croatian and Serbian sample, the student t-test, Mann-Whitney-U, or chi-square tests were used 147 depending on the variable type and data distribution. P-values less than 0.05 were considered to be 148 statistically significant and statistical analysis was performed using IBM's SPSS Statistics Most pharmacies in both countries implemented various safety measures, although more 164 significantly in Croatia than in Serbia, such as, wearing protective gloves or working behind acrylic 165 glass partitions (Table 2 ). More than 95% of the participants in both countries wore face masks at 166 work. However, body temperature checks prior to starting work were less common, particularly in 167 Serbia (67.7% vs. 15.4% in Croatian and Serbia, respectively; p < 0.001). Croatia (mean value 4.13 ± 0.842 to 4.52 ± 0.721) (p < 0.001; Figure 1 ). 184 Approximately two-thirds of the participants reported on providing frequent counseling activities 186 related to public health issues such as preventive measures against COVID-19 infection. In addition, 187 they dedicated significant amounts of time counseling on pre-existing chronic conditions; half to 188 one-third of the participants reported paying equal attention to chronic disease management as 189 before, though more significantly in Serbia than Croatia (78.4% vs. 55.5%; p < 0.001). Overall, 190 Serbian pharmacists reported on conducting significantly more counseling activities than their 191 Croatian counterparts (p < 0.001 for all activities; Figure 2 Faced with supply issues, they had to manage shortages, as presented in Figure 3 . More 212 participants in Croatia reported that they had been rationing certain drugs (90.2% vs. 58.9%; p < 213 0.001) and PPE (97.0% vs. 93.1%; p = 0.031; Figure 3 ). Most of the pharmacists in both countries 214 reported to have provided patients and/or physicians with counseling on therapeutic alternatives 215 due to shortages of certain medicines (91.8% and 95.5% in Croatia and Serbia, respectively; p = 216 0.073; Figure 3 ). 217 In both countries, participants reported providing additional services; approximately 30.7% 218 had started manufacturing hand sanitizers and 17.8% provided online counseling (Figure 4 ). 219 However, the Serbian sample provided home delivery of medicines at a significantly higher rate 220 (22.0% vs. 32.9%; p = 0.003; Figure 4 ). 221 Concerning public perception of their role, there was a sentiment of dissatisfaction, 222 especially pharmacists as public health advisors, especially at a time when other healthcare professionals were 287 not available. As people faced difficulties accessing general practitioners (GPs), dentists, and 288 hospitals, the drastic increase in demand for pharmacy services compounded their plight. According 289 to the Royal College of General Practitioners, face-to-face consultations with GPs decreased from 290 more than 70% in mid-March to 23% in early April 26 . Therefore, the role of community pharmacists 291 expanded to include chronic disease management like ensuring the availability of chronic disease 292 medication, supporting rational medicine use, medication adherence, medication review, and 293 follow-up services 19 . These conditions altered their working hours and work practices leading to 294 work overload, with increased risk of infection, and extreme stress 5 . 295 Current information is crucial for the adequate provision of pharmaceutical care. Getting 296 reliable information at the beginning of the outbreak was quite challenging, as a large proportion of 297 the news in the mass media lacked scientific sources. For example, after public media published the 298 hypothesis that ACE-inhibitors and nonsteroidal anti-inflammatory drugs could have negative effects 299 on the treatment of COVID-19, both patients and pharmacists had reservations about these 300 therapies. Up to 22% of the sample expressed that they did not feel competent in providing up-to-301 date information on the effect of certain drugs in the treatment of COVID-19. This indicates the need 302 for urgent support of professional bodies in the provision of evidence-based information in such 303 circumstances. 304 During the COVID-19 virus outbreak, pharmacists have suffered from prolonged stressful 305 situations and increased workloads, which pose a risk to the health system in terms of increasing 306 errors and the greater likelihood of infection resulting in absence from the workplace. A 307 psychological burden was detected, particularly fear of infection and fear for the health of their 308 loved ones. This fear, according to recently published data, is justified because primary care workers 309 are at an increased risk of infection due to their occupational exposure 27 . Similar findings were 310 reported by Lange et al. 9 , where up to 35% of pharmacists had psychological disturbances as a result 311 of the pandemic, while Ashiru-Oredope et al. 10 found that more than 65% participants were very 312 worried or extremely worried about the impact of COVID-19. 313 To the best of our knowledge, this is the first study to explore multiple dimensions of 314 community pharmacy organization during the COVID-19 pandemic in two neighboring European 315 countries. Although pharmacists have successfully implemented protective measures, maintaining a 316 stable supply of medication and PPE and responding to patients' specific demands, other challenges 317 have risen. First, the system was not prepared for the management of this outbreak. Second, 318 pharmacists exhibited a high psychological burden and were dissatisfied with the recognition of their 319 role in the eyes of the public. Regulatory authorities and professional bodies should recognize the 320 shortcomings raised in this study to improve the pharmacy sector from both professional and public 321 health perspectives. The pharmacists as individuals, also need support. 322 The pandemic has shown the need for a strategy to manage the sector during major crises, 323 which would allow for rapid and effective adaptation to threats. In addition, it is an opportunity for 324 pharmacists to become more involved in crisis management and avail their competencies in a range 325 of new services 28, 29 . 326 Using an on-line survey as a method of data collection could have been a source of selection 328 bias. Specifically, nonresponse bias, as the common type of selection bias, could be the limitation of 329 this study. We could not determine the response rate with certainty, because the recruiting was 330 conducted via interest groups on social media and the exact number of pharmacists who were 331 reached by the used method is unknown. However, the characteristics of our sample (gender 332 proportion, level of education etc.) correspond to those of the population of interest; hence, we 333 believe that selection bias is minimal in this study. Moreover, we reached approximately 10% of the 334 overall community pharmacists' population in each country, which is satisfactory, especially in the 335 circumstances of the onset of the pandemic. Another limitation of the study is that questions in 336 section D could not be validated completely. The questions on psychological aspects are specific for 337 the COVID-19 pandemic, a new and unknown situation, and there was no previously validated 338 questionnaire available to explore the aspects of interest. The design of our questionnaire was time 339 consuming, consisting of previous literature search and interviews with the community pharmacists 340 to identify specific themes, which was subsequently piloted in Croatian and Serbian population and 341 validated for the content. These processes, in the circumstances of the pandemic did not allow for 342 an extra time and sample to be used for complete validation. However, that enables collecting data 343 at the beginning of the outbreak what reduced recall bias. 344 This study suggests that the threat of infection due to workplace exposure have an effect on the 346 psychological state of the health workers, regardless of the country where they practice. Despite 347 these challenges, they have taken on an important role in the healthcare system and responded 348 dutifully to the pandemic by implementing safety measures, managing supply, and providing 349 pharmaceutical care to the population. The extent of systematic and logistical support provided to 350 the sector during the pandemic could explain the differences between the two nations' responses 351 and pharmacists' satisfaction. A more coordinated response from primary care health workers in the 352 future will require better support from regulatory bodies and professional societies. It is necessary 353 to gather the experiences of other countries and prepare strategies to respond to future crises, 354 based on best practices. 355 • The Croatian Pharmacy Chamber responded promptly to the crisis and made specific recommendations for the pharmacists in Croatia. These recommendations included detailed safety measures as well as restrictions concerning the dispensation of specific prescription and non-prescription medicines and PPE, to prevent shortages of these products. • Working hours of community pharmacies during pandemic were defined by Crisis Headquarter and all pharmacies should work part time (from 8 am-5 pm), except on-duty pharmacy. • Due to the compromised availability of PPE, authorities only prescribed the mandatory use of face masks for all pharmacy employees and all users of the pharmacy services much later (July 13, 2020). At the beginning of the pandemic, this equipment was mostly available for healthcare professionals, while patients found alternative means of protecting themselves. • The first confirmed case of the SARS-CoV-2 infection was on March 6, 2020 11 . • The highest number of daily new cases was 445 (total population 8,725,434; 51 new cases per 1 million) on April 16, 2020. 12 • Authorities enacted nationwide lockdown measures on March 15, 2020, which remained in place until May 6, 2020 14, 15 . During this time, they also imposed strict curfews from late evening until the early morning hours and sometimes for consecutive days, the longest of which lasted 4 days. The movement restrictions affected the entire population except for necessity, work, and health emergencies where special licenses were issued. • All community pharmacies remained operational without working hours restrictions except those located in shopping malls. • Pharmacists initially did not have enough PPE, therefore they used various means to prevent viral transmission (by adjusting work practice, work place, the size of teams working different shifts, using handmade PPE such as face shields, and sewing face masks etc.). The work practice was not uniform and differed among the pharmacy chains. 0.003** IQR-interquartile range * P value obtained by Mann-Whitney test ** P value obtained by Chi-square *** Additional postgraduate education (postgraduate studies, specialization, PhD) **** Independent pharmacy (1 community pharmacy); small chain (2-4 pharmacies); medium chain (5-9 pharmacies); large chain (> 10 pharmacies) ***** Differing operating hours (i.e., 8 am-8 pm, 7 am-9 pm, 7 am-8 pm, 8 am-9 pm, 10 am-10 pm, 8 am-10 pm, etc.) Press Release: Community pharmacists in the frontline in the fight against the novel coronavirus disease Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak Knowledge, awareness and preparedness regarding coronavirus disease 2019 pandemic among community pharmacy practitioners working in Kathmandu, Nepal: A pilot study A national study to assess pharmacists' preparedness against COVID-19 during its rapid rise period in Pakistan Pandemic preparedness of community pharmacies for COVID-19 Pharmacy preparedness and response for the prevention and control of coronavirus disease (COVID-19) in Aksum, Ethiopia; a qualitative exploration Role of Pharmacists in COVID-19 Disease: A Jordanian Perspective Epub ahead of print Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information Impact on mental health of the COVID-19 outbreak among community pharmacists during the sanitary lockdown period Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries Health Care Act. Official Gazette of the Republic of Croatia The Regulatory act about the official lockdown announcement. Official Gazette of the Republic of Serbia International Pharmaceutical federation. FIP Covid-19 Information Hub, FIP guidelines and summaries Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries Pharmacists reinventing their roles to effectively respond to COVID-19: A global report from the international pharmacists for anticoagulation care taskforce (iPACT) Community Pharmacists: On the frontline of health service against COVID-19 in LMICs COVID-19: How did community pharmacies get through the first wave? Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages Andrija Štampar: charismatic leader of social medicine and international health COVID-19: a danger and an opportunity for the future of general practice Community pharmacists' exposure to COVID-19 The challenges of COVID-19 for community pharmacists and opportunities for the future Providing pharmacy services during the coronavirus pandemic Authors' contributions: Helen Novak: questionnaire construction, data collection managing in Croatia, graphical presentation of data, writing-review and editing. Ivana Tadić: questionnaire validation and adaptation for Serbia, data collection managing in Serbia, writing-original draft, writing-review and editing. Slaven Falamić: questionnaire validation, data interpretation, writingoriginal draft, writing-review and editing. Maja Ortner Hadžiabdić: conceptualization, methodology, project administration, statistical analysis, supervision, writing-original draft, writing-review and editing.